Assessing the Long-Term Effectiveness of Cladribine vs. Placebo in the Relapsing-Remitting Multiple Sclerosis CLARITY Randomized Controlled Trial and CLARITY Extension Using Treatment Switching Adjustment Methods
Crossref DOI link: https://doi.org/10.1007/s12325-019-01140-z
Published Online: 2019-11-07
Published Print: 2020-01
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Bell Gorrod, Helen
Latimer, Nicholas R.
Damian, Doris
Hettle, Robert
Harty, Gerard T.
Wong, Schiffon L.
Funding for this research was provided by:
EMD Serono
Text and Data Mining valid from 2019-11-07
Version of Record valid from 2019-11-07
Article History
Received: 12 June 2019
First Online: 7 November 2019